Phase I Hematology/Oncology Clinical Investigator (Assistant/Associate Professor)

/Associate Professor) Below you will find the details for the position including any supplementary documentation and questions you should review before applying for the opening. To apply for the position, please click the link/button. If you would like to bookmark this position for later review, click on the Bookmark link. If you would like to print a copy of this position for your records, click on the Print Preview link.

Bookmark this Posting Print Preview | Please see Special Instructions for more details. Applicants should submit a CV, a cover letter detailing how the candidate’s work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information or upload reference letters. Position Details Position Information Recruitment/Posting Title Phase I Hematology/Oncology Clinical Investigator (Assistant/Associate Professor) Department CINJ - Medical Solid Tumor Salary Details A minimum of $283,010 for assistant professor or $344,678, for associate professor. Offer Information The final salary offer may be determined by several factors, including, but not limited to, the candidate’s qualifications, experience, and expertise, and availability of department or grant funds to support the position.

We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university’s broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Benefits

Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include: Medical, prescription drug, and dental coverage Paid vacation, holidays, and various leave programs Competitive retirement benefits, including defined contribution plans and voluntary tax-deferred savings options Employee and dependent educational benefits (when applicable) Life insurance coverage Employee discount programs Posting Summary Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to join and help grow our Phase 1 Experimental Therapeutics Program . The successful candidate will play a key role in the design, conduct, and expansion of early-phase clinical trials while increasing patient access to innovative cancer therapies at New Jersey’s only NCI -Designated Comprehensive Cancer Center and across the RWJBarnabas Health system. Candidates with an interest in Phase I trial development and translational research are encouraged to apply .

Disease specialization is flexible and will be aligned with the successful candidate’s clinical and research interests with opportunities to maintain and grow a disease-specific practice while participating in a robust early-phase therapeutics program. Opportunity Highlights Conduct and develop early-phase clinical trials, including first-in-human, targeted therapy, immuno-oncology, and combination studies. Ensure protocol adherence and compliance with ICH - GCP , FDA regulations (21 CFR ), IRB requirements, and institutional SOPs . Author and review protocols, informed consent documents, abstracts, and manuscripts.

Interpret and integrate pharmacokinetic (PK), pharmacodynamic (PD), and correlative/biomarker data into clinical decision-making. Collaborate with sponsors, CROs, translational scientists, pharmacists, and research coordinators to advance study conduct and portfolio growth. Contribute to feasibility assessments, site selection, for new early-phase trials and expand access throughout the RWJBarnabas Health network. Mentor students, housestaff, fellows, and junior faculty, and research staff.

Startup support and research infrastructure will be provided to facilitate clinical trial development and academic growth. The successful candidate will join the faculty of Rutgers Robert Wood Johnson Medical School on the Clinical Scholar track, with approximately 0.6 clinical FTE dedicated to supporting both academic and clinical priorities. Clinical practice will be located in the Jack & Sheryl Morris Cancer Center , a state-of-the-art, freestanding cancer hospital designed to advance cancer research and patient care through multidisciplinary collaboration. See all our open faculty positions here !

Position Status Full Time Posting Number 26FA0770 Posting Open Date 09/14/2026 Posting Close Date 06/01/2027 Qualifications Minimum Education and Experience Qualified candidates must have: MD or equivalent degree Completed or completing an accredited Hematology/Oncology fellowship program Board Certified or Board Eligible in Medical Oncology and/or Hematology Eligible for or currently holding a New Jersey medical license Demonstrated interest and experience in clinical research Certifications/Licenses Required Knowledge, Skills, and Abilities Preferred Qualifications Experience in Phase I or early-phase clinical trials is preferred. Candidates at mid-senior level with experience and expertise in conducting and leading clinical research. Equipment Utilized Physical Demands and Work Environment Overview RBHS New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences ( RBHS ) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research.

Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School As one of the nation’s comprehensive medical schools, Rutgers Robert Wood Johnson Medical School ( RWJMS ) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school’s principal affiliate, they comprise New Jersey’s premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below.

The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013. Rutgers Cancer Institute As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education.

Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state’s only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences ( RBHS ).

The Jack and Sheryl Morris Cancer Center , located adjacent to Rutgers Cancer Institute and Robert Wood Johnson University Hospital, is New Jersey’s first freestanding cancer hospital. The 510,000-square-foot facility features comprehensive outpatient and inpatient clinical space, including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. The center also includes state-of-the-art research laboratories designed to advance critical scientific investigation and provide opportunities for physician-scientists to translate discoveries directly to patient care. In addition, the Jack and Sheryl Morris Cancer Center brings together comprehensive cancer care, research, wellness, and education resources in one location.

Learn more about the facility at www.cinj.org/jackandsherylmorriscancercenter . Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute’s Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices ( GMP ) facility. Visit Center of Excellence in Cancer Immunology and Metabolism . Statement Rutgers Cancer Institute , the state’s only NCI -designated Comprehensive Cancer Center and RWJBarnabas Health, the state’s largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home.

This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and bas